난독증 치료 시장, 점유율, 규모, 동향, 산업 분석 보고서 : 유형별, 치료 유형별, 최종사용자별, 지역별, 부문별 예측(2024-2032년)

The global dyslexia treatment market size is expected to reach USD 54.90 billion by 2032, according to a new study by Polaris Market Research. The report "Dyslexia Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Phonological Dyslexia, Surface Dyslexia, and Others); By Therapy Type; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Growing awareness of dyslexia as a specific learning disability and increasing recognition of the importance of early intervention for children with dyslexia along with the focus of healthcare providers on identifying dyslexia in its early stages, are primary factors driving the growth of the global market. Growing efforts to develop new potential applications to cure dyslexia by major healthcare companies worldwide and continuous growth in the specific diagnostic rate particularly in emerging economies, as they are becoming more aware of dyslexia, has also been driving the market demand and growth over the years.

For instance, in January 2022, Walsh University, introduced new "Master of Dyslexia Therapy" degree, which is especially designed to address Ohio school, to provide services & screening for children suffering with the dyslexia.

There is a growing emphasis on early intervention for dyslexia with schools and educational institutions increasingly adopting evidence-based strategies to identify and support children with dyslexia at an early age, and could generate huge growth potential for the market.

Various software programs and applications have been developed in the last few years to help individuals with dyslexia improve their reading skills, as these programs use interactive exercises and games to engage users and provide personalized instruction. Besides this, various special fonts and typefaces have been designed across the globe with a focus on making reading easier for dyslexic individuals because these fonts feature modified characters and spacing to reduce confusion between letters and words and help individuals.

Furthermore, there has been a rising adoption of telehealth and teletherapy services that have expanded access to dyslexia assessment and treatment, as it provides significant opportunities for companies to reach individuals in underserved areas and allows for more flexible and convenient care delivery.

Dyslexia Treatment Market Report Highlights

The phonological dyslexia segment accounted for a notable market share, mainly due to increasing awareness among people about the availability of innovative, accurate diagnosis

The occupational therapy segment held the majority revenue share, its rising proliferation drives as a holistic approach to treatment

The home care segment will grow at the highest growth rate on account of a surge in the number of patients preferring home care due to its higher comfort and familiar treatment

North America dominated the global market with substantial share, owing to the region's well-developed healthcare expenditure and supportive government laws

The key market players include Kurzwell Education, Cogmed, Eli Lilly & Company, Jubiliant Pharma Limited, Pearson PLC, Pfizer Inc., and Teva Pharmaceutical

Polaris Market Research has segmented the dyslexia treatment market report based on type, therapy type, end user, and region:

Dyslexia Treatment, Type Outlook (Revenue - USD Billion, 2019 - 2032)

• Phonological Dyslexia
• Surface Dyslexia
• Others

Dyslexia Treatment, Therapy Outlook (Revenue - USD Billion, 2019 - 2032)

• Occupational Therapy
• Speech Therapy
• Cognitive Behavioural Therapy

Dyslexia Treatment, End User Outlook (Revenue - USD Billion, 2019 - 2032)

• Specialty Center
• Home Care
• Hospitals and Clinics
• Others

Dyslexia Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Latin America
• Argentina
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Dyslexia Treatment Market Insights

• 4.1. Dyslexia Treatment Market - End User Snapshot
• 4.2. Dyslexia Treatment Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Development of virtual reality-based educational software and growing incidences of dyslexia
    • 4.2.1.2. Increasing awareness and early diagnosis
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Stigma and social perception
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Dyslexia Treatment Market End User Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Dyslexia Treatment Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
• 5.3. Phonological Dyslexia
  • 5.3.1. Global Dyslexia Treatment Market, by Phonological Dyslexia, by Region, 2019-2032 (USD Billion)
• 5.4. Surface Dyslexia
  • 5.4.1. Global Dyslexia Treatment Market, by Surface Dyslexia, by Region, 2019-2032 (USD Billion)
• 5.5. Others
  • 5.5.1. Global Dyslexia Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Dyslexia Treatment Market, by Therapy Type

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
• 6.3. Occupational Therapy
  • 6.3.1. Global Dyslexia Treatment Market, by Occupational Therapy, by Region, 2019-2032 (USD Billion)
• 6.4. Speech Therapy
  • 6.4.1. Global Dyslexia Treatment Market, by Speech Therapy, by Region, 2019-2032 (USD Billion)
• 6.5. Cognitive Behavioural Therapy
  • 6.5.1. Global Dyslexia Treatment Market, by Cognitive Behavioural Therapy, by Region, 2019-2032 (USD Billion)

7. Global Dyslexia Treatment Market, by End User

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
• 7.3. Specialty Center
  • 7.3.1. Global Dyslexia Treatment Market, by Specialty Center, By Region, 2019-2032 (USD Billion)
• 7.4. Home Care
  • 7.4.1. Global Dyslexia Treatment Market, by Home Care, By Region, 2019-2032 (USD Billion)
• 7.5. Hospitals and Clinics
  • 7.5.1. Global Dyslexia Treatment Market, by Hospitals and Clinics, By Region, 2019-2032 (USD Billion)
• 7.6. Others
  • 7.6.1. Global Dyslexia Treatment Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Dyslexia Treatment Market, by Geography

• 8.1. Key findings
• 8.2. Introduction
  • 8.2.1. Dyslexia Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
• 8.3. Dyslexia Treatment Market - North America
  • 8.3.1. North America: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
  • 8.3.2. North America: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
  • 8.3.3. North America: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.3.4. Dyslexia Treatment Market - U.S.
    • 8.3.4.1. U.S.: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.3.4.2. U.S.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.3.4.3. U.S.: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.3.5. Dyslexia Treatment Market - Canada
    • 8.3.5.1. Canada: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.3.5.2. Canada.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.3.5.3. Canada: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
• 8.4. Dyslexia Treatment Market - Europe
  • 8.4.1. Europe: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
  • 8.4.2. Europe.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
  • 8.4.3. Europe: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.4.4. Dyslexia Treatment Market - UK
    • 8.4.4.1. UK: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.4.2. UK.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.4.4.3. UK: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.4.5. Dyslexia Treatment Market - France
    • 8.4.5.1. France: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.5.2. France.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.4.5.3. France: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.4.6. Dyslexia Treatment Market - Germany
    • 8.4.6.1. Germany: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.6.2. Germany.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.4.6.3. Germany: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.4.7. Dyslexia Treatment Market - Italy
    • 8.4.7.1. Italy: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.7.2. Italy.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.4.7.3. Italy: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.4.8. Dyslexia Treatment Market - Spain
    • 8.4.8.1. Spain: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.8.2. Spain.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.4.8.3. Spain: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.4.9. Dyslexia Treatment Market - Netherlands
    • 8.4.9.1. Netherlands: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.9.2. Netherlands.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.4.9.3. Netherlands: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.4.10. Dyslexia Treatment Market - Russia
    • 8.4.10.1. Russia: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.10.2. Russia.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.4.10.3. Russia: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
• 8.5. Dyslexia Treatment Market - Asia Pacific
  • 8.5.1. Asia Pacific: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
  • 8.5.2. Asia Pacific.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
  • 8.5.3. Asia Pacific: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.5.4. Dyslexia Treatment Market - China
    • 8.5.4.1. China: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.4.2. China.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.5.4.3. China: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.5.5. Dyslexia Treatment Market - India
    • 8.5.5.1. India: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.5.2. India.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.5.5.3. India: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.5.6. Dyslexia Treatment Market - Malaysia
    • 8.5.6.1. Malaysia: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.6.2. Malaysia.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.5.6.3. Malaysia: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.5.7. Dyslexia Treatment Market - Japan
    • 8.5.7.1. Japan: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.7.2. Japan.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.5.7.3. Japan: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.5.8. Dyslexia Treatment Market - Indonesia
    • 8.5.8.1. Indonesia: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.8.2. Indonesia.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.5.8.3. Indonesia: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.5.9. Dyslexia Treatment Market - South Korea
    • 8.5.9.1. South Korea: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.9.2. South Korea.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.5.9.3. South Korea: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
• 8.6. Dyslexia Treatment Market - Middle East & Africa
  • 8.6.1. Middle East & Africa: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
  • 8.6.2. Middle East & Africa.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
  • 8.6.3. Middle East & Africa: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.6.4. Dyslexia Treatment Market - Saudi Arabia
    • 8.6.4.1. Saudi Arabia: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.6.4.2. Saudi Arabia.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.6.4.3. Saudi Arabia: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.6.5. Dyslexia Treatment Market - UAE
    • 8.6.5.1. UAE: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.6.5.2. UAE.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.6.5.3. UAE: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.6.6. Dyslexia Treatment Market - Israel
    • 8.6.6.1. Israel: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.6.6.2. Israel.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.6.6.3. Israel: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.6.7. Dyslexia Treatment Market - South Africa
    • 8.6.7.1. South Africa: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.6.7.2. South Africa.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.6.7.3. South Africa: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
• 8.7. Dyslexia Treatment Market - Latin America
  • 8.7.1. Latin America: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
  • 8.7.2. Latin America.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
  • 8.7.3. Latin America: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.7.4. Dyslexia Treatment Market - Mexico
    • 8.7.4.1. Mexico: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.7.4.2. Mexico.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.7.4.3. Mexico: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.7.5. Dyslexia Treatment Market - Brazil
    • 8.7.5.1. Brazil: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.7.5.2. Brazil.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.7.5.3. Brazil: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.7.6. Dyslexia Treatment Market - Argentina
    • 8.7.6.1. Argentina: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.7.6.2. Argentina.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.7.6.3. Argentina: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)

9. Competitive Landscape

• 9.1. Expansion and Acquisition Analysis
  • 9.1.1. Expansion
  • 9.1.2. Acquisitions
• 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

• 10.1. Cogmed
  • 10.1.1. Company Overview
  • 10.1.2. Financial Performance
  • 10.1.3. Product Benchmarking
  • 10.1.4. Recent Development
• 10.2. CogniFit
  • 10.2.1. Company Overview
  • 10.2.2. Financial Performance
  • 10.2.3. Product Benchmarking
  • 10.2.4. Recent Development
• 10.3. Dyslexia Action Group Holdings Ltd.
  • 10.3.1. Company Overview
  • 10.3.2. Financial Performance
  • 10.3.3. Product Benchmarking
  • 10.3.4. Recent Development
• 10.4. Eli Lilly & Company
  • 10.4.1. Company Overview
  • 10.4.2. Financial Performance
  • 10.4.3. Product Benchmarking
  • 10.4.4. Recent Development
• 10.5. Gemm Learning
  • 10.5.1. Company Overview
  • 10.5.2. Financial Performance
  • 10.5.3. Product Benchmarking
  • 10.5.4. Recent Development
• 10.6. Jubiliant Pharma Limited
  • 10.6.1. Company Overview
  • 10.6.2. Financial Performance
  • 10.6.3. Product Benchmarking
  • 10.6.4. Recent Development
• 10.7. Kurzweil Education
  • 10.7.1. Company Overview
  • 10.7.2. Financial Performance
  • 10.7.3. Product Benchmarking
  • 10.7.4. Recent Development
• 10.8. Lindamood Bell
  • 10.8.1. Company Overview
  • 10.8.2. Financial Performance
  • 10.8.3. Product Benchmarking
  • 10.8.4. Recent Development
• 10.9. Lyfta
  • 10.9.1. Company Overview
  • 10.9.2. Financial Performance
  • 10.9.3. Product Benchmarking
  • 10.9.4. Recent Development
• 10.10. Nessy Learning LLC
  • 10.10.1. Company Overview
  • 10.10.2. Financial Performance
  • 10.10.3. Product Benchmarking
  • 10.10.4. Recent Development
• 10.11. NeuroNet Learning
  • 10.11.1. Company Overview
  • 10.11.2. Financial Performance
  • 10.11.3. Product Benchmarking
  • 10.11.4. Recent Development
• 10.12. Novartis AG
  • 10.12.1. Company Overview
  • 10.12.2. Financial Performance
  • 10.12.3. Product Benchmarking
  • 10.12.4. Recent Development
• 10.13. Pearson PLC
  • 10.13.1. Company Overview
  • 10.13.2. Financial Performance
  • 10.13.3. Product Benchmarking
  • 10.13.4. Recent Development
• 10.14. Pfizer Inc.
  • 10.14.1. Company Overview
  • 10.14.2. Financial Performance
  • 10.14.3. Product Benchmarking
  • 10.14.4. Recent Development
• 10.15. RPG Lifesciences
  • 10.15.1. Company Overview
  • 10.15.2. Financial Performance
  • 10.15.3. Product Benchmarking
  • 10.15.4. Recent Development
• 10.16. Scientific Learning Corporation
  • 10.16.1. Company Overview
  • 10.16.2. Financial Performance
  • 10.16.3. Product Benchmarking
  • 10.16.4. Recent Development
• 10.17. Teva Pharmaceutical Industries
  • 10.17.1. Company Overview
  • 10.17.2. Financial Performance
  • 10.17.3. Product Benchmarking
  • 10.17.4. Recent Development